Marriage of two technologies gives sensitive assay
This article was originally published in Clinica
Executive Summary
Research published in September's issue of Clinical Chemistry describes how the combination of two sensitive techniques has produced a new type of homogenous chemiluminescent immunoassay. Behring Diagnostics, a division of Hoechst, is developing the technology for the market.